| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |